BlackRock Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$295M Sell
13,644,787
-253,900
-2% -$5.54M 0.14% 171
2016
Q3
$331M Sell
13,898,687
-1,062,967
-7% -$25.4M 0.17% 142
2016
Q2
$350M Sell
14,961,654
-636,380
-4% -$13.8M 0.18% 128
2016
Q1
$293M Buy
15,598,034
+210,468
+1% +$3.7M 0.16% 148
2015
Q4
$284M Buy
15,387,566
+304,388
+2% +$5.45M 0.16% 145
2015
Q3
$248M Buy
15,083,178
+773,815
+5% +$13.2M 0.14% 161
2015
Q2
$253M Buy
14,309,363
+468,357
+3% +$8.37M 0.14% 176
2015
Q1
$246M Buy
13,841,006
+1,762,665
+15% +$27.9M 0.13% 182
2014
Q4
$160M Buy
12,078,341
+1,017,739
+9% +$13M 0.09% 276
2014
Q3
$131M Sell
11,060,602
-149,398
-1% -$1.88M 0.08% 301
2014
Q2
$143M Buy
11,210,000
+24,006
+0.2% +$312K 0.08% 282
2014
Q1
$151M Sell
11,185,994
-818,619
-7% -$10.7M 0.09% 244
2013
Q4
$144M Sell
12,004,613
-248,923
-2% -$2.94M 0.09% 248
2013
Q3
$144M Buy
12,253,536
+1,834,958
+18% +$19.8M 0.1% 239
2013
Q2
$96.6M Buy
+10,418,578
New +$88.4M 0.07% 301

Other funds holding BSX

BlackRock Group's BSX Position: Q4 2016 in Review

BlackRock Group reduced its Boston Scientific (BSX) stake by 1.8% in Q4 2016, selling an estimated $5.54M and leaving 13,644,787 shares worth $295M. The position accounts for 0.14% of the portfolio, ranked #171.

BlackRock Group first reported a position in BSX in Q2 2013 and has held it in 15 quarters since. The position peaked at $350M in Q2 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

  • BlackRock Group held 13,644,787 shares of Boston Scientific worth $295M as of Q4 2016.
  • BlackRock Group sold 253,900 Boston Scientific shares in Q4 2016, an estimated $5.54M.
  • Boston Scientific made up 0.14% of BlackRock Group's portfolio in Q4 2016, its #171 holding.
  • BlackRock Group first reported a position in Boston Scientific in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Boston Scientific position peaked at $350M in Q2 2016.
  • 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.